Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium.
Maximilian FethNatasha WeaverRobert B FanningSung-Min ChoMatthew J GriffeeMauro PanigadaAkram M ZaaqoqAhmed LabibGlenn J R WhitmanRakesh C AroraBo S KimNicole WhiteJacky Y SuenGianluigi Li BassiGiles J PeekRoberto LorussoHeidi DaltonJohn F FraserJonathon P Fanningnull nullPublished in: Journal of intensive care (2024)
Coagulation disorders are frequent in COVID-19 ARDS patients receiving ECMO. Bleeding events contribute substantially to mortality in this cohort. However, this risk may be lower than previously reported in single-nation studies or early case reports. Trial registration ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 ).
Keyphrases
- extracorporeal membrane oxygenation
- sars cov
- acute respiratory distress syndrome
- coronavirus disease
- respiratory failure
- respiratory syndrome coronavirus
- mechanical ventilation
- case control
- study protocol
- clinical trial
- randomized controlled trial
- atrial fibrillation
- pulmonary embolism
- cardiovascular disease
- risk factors
- type diabetes
- intensive care unit
- cardiovascular events